These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17631852)

  • 21. Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration.
    Kim IK; Ji F; Morrison MA; Adams S; Zhang Q; Lane AM; Capone A; Dryja TP; Ott J; Miller JW; DeAngelis MM
    Mol Vis; 2008 Aug; 14():1487-95. PubMed ID: 18704199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotype-phenotype correlation of age-related macular degeneration: influence of complement factor H polymorphism.
    Droz I; Mantel I; Ambresin A; Faouzi M; Schorderet DF; Munier FL
    Br J Ophthalmol; 2008 Apr; 92(4):513-7. PubMed ID: 18211923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of complement factor H Y402H, LOC387715, HTRA1 polymorphisms and ApoE alleles with susceptibility to age-related macular degeneration in Hungarian patients.
    Losonczy G; Fekete Á; Vokó Z; Takács L; Káldi I; Ajzner É; Kasza M; Vajas A; Berta A; Balogh I
    Acta Ophthalmol; 2011 May; 89(3):255-62. PubMed ID: 19845562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration.
    Nischler C; Oberkofler H; Ortner C; Paikl D; Riha W; Lang N; Patsch W; Egger SF
    Acta Ophthalmol; 2011 Jun; 89(4):e344-9. PubMed ID: 21232084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration.
    Schaumberg DA; Christen WG; Kozlowski P; Miller DT; Ridker PM; Zee RY
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2336-40. PubMed ID: 16723442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human complement factor H Y402H polymorphism causes an age-related macular degeneration phenotype and lipoprotein dysregulation in mice.
    Landowski M; Kelly U; Klingeborn M; Groelle M; Ding JD; Grigsby D; Bowes Rickman C
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3703-3711. PubMed ID: 30808757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials.
    Lin LY; Zhou Q; Hagstrom S; Maguire MG; Daniel E; Grunwald JE; Martin DF; Ying GS;
    JAMA Ophthalmol; 2018 Jun; 136(6):682-688. PubMed ID: 29801032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of complement factor H gene polymorphisms with age-related macular egeneration susceptibility.
    Hao XF; Xie LK; Tang YZ; Xie WK; Zhang ZF; Qi YX; Xiao WZ; Zhang J
    Int J Clin Exp Pathol; 2015; 8(3):3186-91. PubMed ID: 26045838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy.
    Jirarattanasopa P; Ooto S; Nakata I; Tsujikawa A; Yamashiro K; Oishi A; Yoshimura N
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3663-72. PubMed ID: 22570352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics of Complement Factor H Y402H Polymorphism and Treatment of Neovascular AMD with Anti-VEGF Agents: A Meta-Analysis.
    Chen G; Tzekov R; Li W; Jiang F; Mao S; Tong Y
    Sci Rep; 2015 Sep; 5():14517. PubMed ID: 26411831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration.
    Despriet DD; Klaver CC; Witteman JC; Bergen AA; Kardys I; de Maat MP; Boekhoorn SS; Vingerling JR; Hofman A; Oostra BA; Uitterlinden AG; Stijnen T; van Duijn CM; de Jong PT
    JAMA; 2006 Jul; 296(3):301-9. PubMed ID: 16849663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral reticular pigmentary change is associated with complement factor H polymorphism (Y402H) in age-related macular degeneration.
    Shuler RK; Schmidt S; Gallins P; Hauser MA; Scott WK; Caldwell J; Agarwal A; Haines JL; Pericak-Vance MA; Postel EA
    Ophthalmology; 2008 Mar; 115(3):520-4. PubMed ID: 18067970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of risk genotypes of ARMS2/LOC387715 A69S and CFH Y402H with age-related macular degeneration with and without reticular pseudodrusen: a meta-analysis.
    Jabbarpoor Bonyadi MH; Yaseri M; Nikkhah H; Bonyadi M; Soheilian M
    Acta Ophthalmol; 2018 Mar; 96(2):e105-e110. PubMed ID: 28593728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population.
    Souied EH; Leveziel N; Richard F; Dragon-Durey MA; Coscas G; Soubrane G; Benlian P; Fremeaux-Bacchi V
    Mol Vis; 2005 Dec; 11():1135-40. PubMed ID: 16379025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ARMS2 A69S variant and bilateral advanced age-related macular degeneration.
    Schwartz SG; Agarwal A; Kovach JL; Gallins PJ; Cade W; Postel EA; Wang G; Ayala-Haedo J; Spencer KM; Haines JL; Pericak-Vance MA; Scott WK
    Retina; 2012 Sep; 32(8):1486-91. PubMed ID: 22481475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement factor H 402H variant and reticular macular disease.
    Smith RT; Merriam JE; Sohrab MA; Pumariega NM; Barile G; Blonska AM; Haans R; Madigan D; Allikmets R
    Arch Ophthalmol; 2011 Aug; 129(8):1061-6. PubMed ID: 21825189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical study of the correlation between complement factor H polymorphism and age-related macular degeneration.
    Dong HT; Zhang JX; Li QM; Li FZ
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab.
    Lee AY; Raya AK; Kymes SM; Shiels A; Brantley MA
    Br J Ophthalmol; 2009 May; 93(5):610-3. PubMed ID: 19091853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different hereditary contribution of the CFH gene between polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese Han people.
    Huang L; Li Y; Guo S; Sun Y; Zhang C; Bai Y; Li S; Yang F; Zhao M; Wang B; Yu W; Zhao M; Khor CC; Li X
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2534-8. PubMed ID: 24692129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population-based study of early age-related macular degeneration: role of the complement factor H Y402H polymorphism in bilateral but not unilateral disease.
    Tedeschi-Blok N; Buckley J; Varma R; Triche TJ; Hinton DR
    Ophthalmology; 2007 Jan; 114(1):99-103. PubMed ID: 17198853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.